Literature DB >> 25279168

β-catenin knockdown enhances the effects of fluorouracil in the breast cancer cell line MDA-MB-468.

Xinquan Lv1, Xia Pang1, Xiangdong Jin1, Yimin Song1, Huixiang Li1.   

Abstract

Tumor proliferation, drug resistance and cell stemness are major difficulties that are encountered during breast cancer therapy and are often responsible for disease progression and cancer-related mortality. β-catenin is considered to be an invasion gene in breast cancer. However, how β-catenin regulates breast cancer cell proliferation and stemness remains unclear. In the present study, β-catenin knockdown by small interfering RNA in MDA-MB-468, a highly metastatic breast cancer cell line, inhibited the expression of β-catenin, Oct3/4 (stemness), survivin (anti-apoptosis) and BCRP (drug resistance). Knockdown of β-catenin enhanced the effects of fluorouracil (5-FU) chemotherapy on the proliferation of MDA-MB-468 cells. Thus, these preliminary results indicate that β-catenin knockdown enhanced 5-FU-induced proliferation inhibition in the breast cancer cell line MDA-MB-468, and indicate that combining 5-FU with gene silencing could be an advantageous option for enhancing the curative effect of chemotherapy in breast cancer and other malignancies.

Entities:  

Keywords:  RNA interference; breast cancer; gene therapy; stem cell; β-catenin

Year:  2014        PMID: 25279168      PMCID: PMC4179739          DOI: 10.3892/br.2014.353

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  24 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

2.  WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells.

Authors:  Wendy A Woodward; Mercy S Chen; Fariba Behbod; Maria P Alfaro; Thomas A Buchholz; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

3.  Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients.

Authors:  Ogan Demir Abaan; Pelin Kaya Mutlu; Yusuf Baran; Can Atalay; Ufuk Gunduz
Journal:  Cancer Invest       Date:  2009-02       Impact factor: 2.176

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 5.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 6.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

Review 7.  β-catenin as a potential key target for tumor suppression.

Authors:  Yuejun Fu; Shuhua Zheng; Na An; Takis Athanasopoulos; Linda Popplewell; Aihua Liang; Ke Li; Changchen Hu; Yajing Zhu
Journal:  Int J Cancer       Date:  2011-06-21       Impact factor: 7.396

8.  New type of POU domain in germ line-specific protein Oct-4.

Authors:  H R Schöler; S Ruppert; N Suzuki; K Chowdhury; P Gruss
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

9.  Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Authors:  Tomonori Tanei; Koji Morimoto; Kenzo Shimazu; Seung Jin Kim; Yoshio Tanji; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

10.  Gene silencing of beta-catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude mice.

Authors:  Jin-Sheng Wang; Chang-Li Zheng; Yong-Jin Wang; Ji-Fang Wen; Hong-Zheng Ren; Ying Liu; Hai-Ying Jiang
Journal:  Dis Esophagus       Date:  2008-11-19       Impact factor: 3.429

View more
  2 in total

1.  Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.

Authors:  Lei Liu; Huixiang Li; Min Zhang; Xinquan Lv
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Selective GPR55 antagonism reduces chemoresistance in cancer cells.

Authors:  Nagendra S Singh; Michel Bernier; Irving W Wainer
Journal:  Pharmacol Res       Date:  2016-07-14       Impact factor: 7.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.